The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Micro RNA‐24 regulates cardiac fibrosis after myocardial infarction
Open accessAbstract
Cardiac fibrosis after myocardial infarction (MI) has been identified as a key factor in the development of heart failure. Although dysregulation of microRNA (miRNA) is involved in various pathophysiological processes in the heart, the role of miRNA in fibrosis regulation after MI is not clear. Previously we observed the correlation between fibrosis and the miR‐24 expression in hypertrophic hearts, herein we assessed how miR‐24 regulates fibrosis after MI. Using qRT‐PCR, we showed that miR‐24 was down‐regulated in the MI heart; the change in miR‐24 expression was closely related to extracellular matrix (ECM) remodelling. In vivo, miR‐24 could improve heart function and attenuate fibrosis in the infarct border zone of the heart two weeks after MI through intramyocardial injection of Lentiviruses. Moreover, in vitro experiments suggested that up‐regulation of miR‐24 by synthetic miR‐24 precursors could reduce fibrosis and also decrease the differentiation and migration of cardiac fibroblasts (CFs). TGF‐β (a pathological mediator of fibrotic disease) increased miR‐24 expression, overexpression of miR‐24 reduced TGF‐β secretion and Smad2/3 phosphorylation in CFs. By performing microarray analyses and bioinformatics analyses, we found furin to be a potential target for miR‐24 in fibrosis (furin is a protease which controls latent TGF‐β activation processing). Finally, we demonstrated that protein and mRNA levels of furin were regulated by miR‐24 in CFs. These findings suggest that miR‐24 has a critical role in CF function and cardiac fibrosis after MI through a furin–TGF‐β pathway. Thus, miR‐24 may be used as a target for treatment of MI and other fibrotic heart diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290 · cited 1×
“These are fast-proliferating, a-smooth muscle cell actin (a-SMA)-positive cells with pronounced contractile and secretory properties [3].”
BackgroundMicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Cardiac fibroblasts: At the heart of myocardial remodeling
Porter, K. E., & Turner, N. A. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.002 · Cited by 1,010
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Duisters, R. F., Tijsen, A. J., Schroen, B., Leenders, J. J., Lentink, V., van der Made, I., Herias, V., van Leeuwen, R. E., Schellings, M. W., Barenbrug, P., et al. (2009) · Circulation Research · doi:10.1161/circresaha.108.182535 · Cited by 816
Myocardial remodeling after infarction: the role of myofibroblasts
van den Borne, S. W. M., Diez, J., Blankesteijn, W. M., Verjans, J., Hofstra, L., & Narula, J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.199 · Cited by 739
MicroRNAs Are Aberrantly Expressed in Hypertrophic Heart
Cheng, Y., Ji, R., Yue, J., Yang, J., Liu, X., Chen, H., Dean, D. B., & Zhang, C. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061170 · Cited by 490
MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease
Hu, S., Huang, M., Li, Z., Jia, F., Ghosh, Z., Lijkwan, M. A., Fasanaro, P., Sun, N., Wang, X., Martelli, F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.928424 · Cited by 462
Self-citationDong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., Wang, D., Krall, T. J., Delphin, E. S., & Zhang, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027896 · Cited by 454 · cited 2×
“For example, miR-21 and miR-29 have been found to have important roles in the growth and apoptosis of cardiac cells [32, 33], and in cardiac fibrosis remodelling [8, 9].”
BackgroundMicroRNA-24 Regulates Vascularity After Myocardial Infarction
Fiedler, J., Jazbutyte, V., Kirchmaier, B. C., Gupta, S. K., Lorenzen, J., Hartmann, D., Galuppo, P., Kneitz, S., Pena, J. T. G., Sohn-Lee, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.039008 · Cited by 393
Small, E. M., Thatcher, J. E., Sutherland, L. B., Kinoshita, H., Gerard, R. D., Richardson, J. A., DiMaio, J. M., Sadek, H., Kuwahara, K., & Olson, E. N. (2010) · Circulation Research · doi:10.1161/circresaha.110.223172 · Cited by 373
miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy
Lin, Z., Murtaza, I., Wang, K., Jiao, J., Gao, J., & Li, P.-F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811371106 · Cited by 359
MicroRNAs and cardiac pathology
Latronico, M. V. G., & Condorelli, G. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.56 · Cited by 324
miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes
Qian, L., Van Laake, L. W., Huang, Y., Liu, S., Wendland, M. F., & Srivastava, D. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101547 · Cited by 322
Stable knockdown of microRNA in vivo by lentiviral vectors
Gentner, B., Schira, G., Giustacchini, A., Amendola, M., Brown, B. D., Ponzoni, M., & Naldini, L. (2009) · Nature Methods · doi:10.1038/nmeth.1277 · Cited by 304
IKEUCHI, M., TSUTSUI, H., SHIOMI, T., MATSUSAKA, H., MATSUSHIMA, S., WEN, J., KUBOTA, T., & TAKESHITA, A. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.07.017 · Cited by 285
TGFβ, cardiac fibroblasts, and the fibrotic response
LEASK, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.07.012 · Cited by 265
Transforming growth factor- -regulated miR-24 promotes skeletal muscle differentiation
Sun, Q., Zhang, Y., Yang, G., Chen, X., Zhang, Y., Cao, G., Wang, J., Sun, Y., Zhang, P., Fan, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn032 · Cited by 261
Self-citationFactor VIII related antigen as an endothelial cell marker in benign and malignant diseases
Sehested, M., & Hou-Jensen, K. (1981) · Virchows Archiv A Pathological Anatomy and Histology · doi:10.1007/bf00437598 · Cited by 258
Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis
Manole, C. G., Cismaşiu, V., Gherghiceanu, M., & Popescu, L. M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01449.x · Cited by 215
Chan, M. C., Hilyard, A. C., Wu, C., Davis, B. N., Hill, N. S., Lal, A., Lieberman, J., Lagna, G., & Hata, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.370 · Cited by 201
Ye, Y., Hu, Z., Lin, Y., Zhang, C., & Perez-Polo, J. R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq053 · Cited by 200
Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat
Sun, Y., Cleutjens, J. P. M., Diaz-Arias, A. A., & Weber, K. T. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.9.1423 · Cited by 198
Lentivirus-mediated antagomir expression for specific inhibition of miRNA function
Scherr, M., Venturini, L., Battmer, K., Schaller-Schoenitz, M., Schaefer, D., Dallmann, I., Ganser, A., & Eder, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm971 · Cited by 190
Okada, H., Takemura, G., Kosai, K.-I., Li, Y., Takahashi, T., Esaki, M., Yuge, K., Miyata, S., Maruyama, R., Mikami, A., et al. (2005) · Circulation · doi:10.1161/01.cir.0000165066.71481.8e · Cited by 185
Latent TGF‐β1 activation by platelets
Blakytny, R., Ludlow, A., Martin, G. E. M., Ireland, G. W., Lund, L. R., Ferguson, M. W. J., & Brunner, G. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10454 · Cited by 131
Zamilpa, R., & Lindsey, M. L. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.06.012 · Cited by 125
miR-193 expression differentiates telocytes from other stromal cells
Cismasiu, V. B., Radu, E., & Popescu, L. M. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01325.x · Cited by 113
Stawowy, P., Margeta, C., Kallisch, H., Seidah, N. G., Chrétien, M., Fleck, E., & Graf, K. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.03.010 · Cited by 110
Luna, C., Li, G., Qiu, J., Epstein, D. L., & González, P. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22476 · Cited by 96
Searching for MiR-acles in Cardiac Fibrosis
van Rooij, E., & Olson, E. N. (2009) · Circulation Research · doi:10.1161/circresaha.108.192492 · Cited by 94
Yoshimitsu, M., Sato, T., Tao, K., Walia, J. S., Rasaiah, V. I., Sleep, G. T., Murray, G. J., Poeppl, A. G., Underwood, J. P., West, L. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407572101 · Cited by 89
Yoshimitsu, M., Higuchi, K., Ramsubir, S., Nonaka, T., Rasaiah, V. I., Siatskas, C., Liang, S.-B., Murray, G. J., Brady, R. O., & Medin, J. A. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302839 · Cited by 55
MicroRNA: Novel Regulators Involved in the Remodeling and Reverse Remodeling of the Heart
Wang, J., Xu, R., Lin, F., Zhang, S., Zhang, G., Hu, S., & Zhe, Z. (2008) · Cardiology · doi:10.1159/000172616 · Cited by 48
Self-citationOrnatowski, W., Poschet, J. F., Perkett, E. A., Taylor‐Cousar, J. L., & Deretic, V. P. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31499 · Cited by 41
Dogar, A. M., Towbin, H., & Hall, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208652 · Cited by 31
Lentivirus-Mediated Antagomir Expression
Surdziel, E., Eder, M., & Scherr, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-811-9_16 · Cited by 10
Cited by
Exosomes as Critical Agents of Cardiac Regeneration Triggered by Cell Therapy
Ibrahim, A. G.-E., Cheng, K., & Marbán, E. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.006 · Cited by 826
Getting to the Heart of the Matter: New Insights Into Cardiac Fibrosis
Leask, A. (2015) · Circulation Research · doi:10.1161/circresaha.116.305381 · Cited by 340
MicroRNAs in Heart Failure: From Biomarker to Target for Therapy
Vegter, E. L., van der Meer, P., de Windt, L. J., Pinto, Y. M., & Voors, A. A. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.495 · Cited by 303
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
“In separate studies, miR-24 was shown to have beneficial effects on cardiomyocytes, fibroblasts, and ECs through the prevention of apoptosis, prevention of fibrosis, and activation of angiogenesis, respectively (24, 99, 141).”
Background
Metadata
- Authors
- Wang, J., Huang, W., Xu, R., Nie, Y., Cao, X., Meng, J., Xu, X., Hu, S., & Zheng, Z.
- Venue
- Journal of Cellular and Molecular Medicine
- Publisher
- Wiley
- Published
- 2012-08-23
- Volume
- 16
- Issue
- 9
- Pages
- 2150-2160
- ISSN
- 1582-1838 (ISSN-L)
- 1582-4934
- OpenAlex
- W2033614137
- Cited by
- 266
- References
- 39
- FWCI
- 16.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.